U.S., April 16 -- An application to own the trademark for 'AMLOGENYX' has been filed on Sep. 11, 2024.
Owner(s):
Amlogenyx Inc.; 77 Digital Drive, Suite 200, , California
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of neurological and genetic diseases and disorders; chemical, biological, and biochemical preparations for use in gene delivery technology for medical use, namely, nucleic acids in the nature of coding and noncoding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and regulatory sequences, for use in in vivo therapeutic use in gene therapy
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-04-15...